Skip to main contentSkip to navigation
Sirius Investors
Merck KGaA

Merck KGaA

MKGAF
OTCHealthcare

Merck KGaA (MKGAF) Investment Research Dashboard

About Merck KGaA (MKGAF) stock analysis

Get live MKGAF stock price $167.51, comprehensive Merck KGaA stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time MKGAF stock data and investment insights.

167.51
2.63%Today
Market Cap
72.83B
Volume
36
52W High
175.56
52W Low
116.68

Loading chart data...

Merck KGaA (MKGAF) Overview

Merck KGaA (MKGAF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, MKGAF trades at $167.51 with a market capitalization of 72.83B . Over the past 52 weeks, MKGAF has traded between $116.68 and $175.56 , with the current price positioned at approximately 86% of this range . The s...

Key Takeaways

  • Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
  • Market cap: 72.83B
  • Current price: $167.51
  • 52-week range: $116.68 - $175.56
  • P/E ratio: 18.95

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Merck KGaA is a venerable science and technology enterprise, headquartered in Darmstadt, Germany, where it was established in 1668. Operating as a subsidiary of E. Merck KG, the company organizes its diverse activities across three principal division...

Company Information

CEO
Kai Beckmann
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
62461

Contact Information

Address
Frankfurter Strasse 250
Country
DE

Investment Analysis & Business Insights

Healthcare
Drug Manufacturers - Specialty & Generic

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 18.9)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Merck KGaA shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Merck KGaA
  • Investors should consider how Merck KGaA fits within their overall portfolio allocation

Market Cap

72.83B

P/E Ratio (TTM)

18.95

Beta

0.82

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

78/100 ⭐⭐⭐⭐⭐

Overall
+0.7%
NYSE
+0.6%
NASDAQ
+0.7%
Sector1D1W1MP/EScore
Financial Services+2.2%+3.1%+4.3%19.3
98/100⭐⭐⭐⭐⭐
Healthcare+0.7%+1.3%+1.6%24.1
78/100⭐⭐⭐⭐⭐
Communication Services+1.4%-0.7%+2.9%22.2
74/100⭐⭐⭐⭐⭐
Consumer Defensive-0.2%+1.8%+0.7%29.7
64/100⭐⭐⭐⭐
Basic Materials+0.4%+1.2%-0.2%25.2
61/100⭐⭐⭐⭐
Real Estate-0.5%+0.0%-2.5%29.2
43/100⭐⭐⭐
Energy-2.1%-3.7%-4.1%19.1
39/100⭐⭐
Utilities-1.0%+0.0%-4.4%26.8
37/100⭐⭐
Industrials+0.6%+0.4%-9.9%30.1
23/100
Consumer Cyclical+0.5%-1.5%-5.8%43.0
18/100
Technology+0.6%-1.6%-7.2%40.7
15/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.